S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NYSE:WAT

Waters (WAT) Stock Forecast, Price & News

$320.42
+6.47 (+2.06%)
(As of 05/13/2022 06:40 PM ET)
Add
Compare
Today's Range
$316.91
$326.32
50-Day Range
$288.88
$342.47
52-Week Range
$288.32
$428.22
Volume
254,000 shs
Average Volume
404,132 shs
Market Capitalization
$19.30 billion
P/E Ratio
28.03
Dividend Yield
N/A
Beta
0.85
30 days | 90 days | 365 days | Advanced Chart
Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

Waters logo

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
94184810
Employees
7,800
Year Founded
1958

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$13.54 per share
Book Value
$6.22 per share

Profitability

Net Income
$692.84 million
Pretax Margin
28.56%

Debt

Price-To-Earnings

Miscellaneous

Free Float
59,771,000
Market Cap
$19.30 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/03/2022
Today
5/16/2022
Next Earnings (Estimated)
8/02/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

1.78 out of 5 stars

Computer And Technology Sector

537th out of 916 stocks

Analytical Instruments Industry

20th out of 32 stocks

Analyst Opinion: 2.1Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Waters (NYSE:WAT) Frequently Asked Questions

Is Waters a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Waters stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
View analyst ratings for Waters
or view top-rated stocks.

When is Waters' next earnings date?

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Waters
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) announced its quarterly earnings data on Tuesday, May, 3rd. The medical instruments supplier reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.32 by $0.48. The medical instruments supplier had revenue of $690.60 million for the quarter, compared to the consensus estimate of $634.08 million. Waters had a net margin of 24.57% and a trailing twelve-month return on equity of 221.08%. The firm's revenue for the quarter was up 13.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.29 EPS.
View Waters' earnings history
.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $2.55-$2.65 for the period, compared to the consensus EPS estimate of $2.78. The company issued revenue guidance of $695.28 million-$708.91 million, compared to the consensus revenue estimate of $706.48 million.

What price target have analysts set for WAT?

5 brokers have issued 12 month price targets for Waters' stock. Their forecasts range from $315.00 to $400.00. On average, they anticipate Waters' share price to reach $365.00 in the next twelve months. This suggests a possible upside of 13.9% from the stock's current price.
View analysts' price targets for Waters
or view top-rated stocks among Wall Street analysts.

Who are Waters' key executives?
Waters' management team includes the following people:
  • Dr. Udit Batra Ph.D., Pres, CEO & Director (Age 51, Pay $1.28M)
  • Dr. Michael C. Harrington Ph.D., Consultant (Age 61, Pay $774.57k) (LinkedIn Profile)
  • Mr. Ian S. King, Consultant (Age 65, Pay $660.98k) (LinkedIn Profile)
  • Mr. Jonathan M. Pratt, Sr. VP of Waters Division (Age 52, Pay $653.3k)
  • Mr. Amol Chaubal, Sr. VP & CFO (Age 45)
  • Mr. Daniel J. Welch, Sr. VP of Global Operations
  • Caspar Tudor, Mang. of Investor Relations
  • Ms. Keeley A. Aleman, Sr. VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Kevin Kempskie, Sr. Director of PR
  • Ms. Kristen Garvey, VP of Corp. Communications
What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters CEO Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among Waters' employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), (HON), Raytheon Technologies (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Who are Waters' major shareholders?

Waters' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.10%), BlackRock Inc. (10.14%), Bank of New York Mellon Corp (6.61%), Massachusetts Financial Services Co. MA (4.09%), Champlain Investment Partners LLC (1.67%) and Northern Trust Corp (1.40%). Company insiders that own Waters stock include Christopher A Kuebler, Christopher J Oconnell, Edward Conard, Ian King, Joann A Reed, Linda Baddour, Michael C Harrington, Michael J Berendt, Robert G Carson, Sherry Buck and Thomas P Salice.
View institutional ownership trends for Waters
.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Marathon Asset Management Ltd, Los Angeles Capital Management LLC, Massachusetts Financial Services Co. MA, Bank of New York Mellon Corp, Acadian Asset Management LLC, First Trust Advisors LP, and Skandinaviska Enskilda Banken AB publ . Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, Edward Conard, Linda Baddour, Michael J Berendt, and Thomas P Salice.
View insider buying and selling activity for Waters
or view top insider-selling stocks.

Which major investors are buying Waters stock?

WAT stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Boston Trust Walden Corp, Tikehau Investment Management, Nordea Investment Management AB, KBC Group NV, Caisse DE Depot ET Placement DU Quebec, BlackRock Inc., and Qube Research & Technologies Ltd.
View insider buying and selling activity for Waters
or or view top insider-buying stocks.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $320.42.

How much money does Waters make?

Waters has a market capitalization of $19.30 billion and generates $2.79 billion in revenue each year. The medical instruments supplier earns $692.84 million in net income (profit) each year or $11.43 on an earnings per share basis.

How many employees does Waters have?

Waters employs 7,800 workers across the globe.

Does Waters have any subsidiaries?

The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).

When was Waters founded?

Waters was founded in 1958.

What is Waters' official website?

The official website for Waters is www.waters.com.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at (508) 478-2000, via email at [email protected], or via fax at 508-872-1990.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.